Aethlon Medical Inc.

1.17+0.1100+10.38%Vol 366.42K1Y Perf -79.50%
Jun 28th, 2022 16:00 DELAYED
BID1.15 ASK1.18
Open1.08 Previous Close1.06
Pre-Market- After-Market1.14
 - -  -0.03 -2.56%
Target Price
7.00 
Analyst Rating
Strong Buy 1.00
Potential %
498.29 
Finscreener Ranking
★★★★★     60.25
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     56.83
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     63.10
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.43 
Earnings Rating
Sell
Market Cap18.03M 
Earnings Date
28th Jun 2022
Alpha0.02 Standard Deviation0.57
Beta0.81 

Today's Price Range

1.081.18

52W Range

0.88006.22

5 Year PE Ratio Range

-4.70-1.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
6.80%
1 Month
-27.65%
3 Months
-26.39%
6 Months
-48.79%
1 Year
-79.50%
3 Years
-80.64%
5 Years
-97.02%
10 Years
-98.34%

TickerPriceChg.Chg.%
AEMD1.170.110010.38
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
19.20
19.80
0.01
0.02
-39 070.10
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
-
-2 822.30
-2 783.90
-4 145.90
-
RevenueValueIndustryS&P 500US Markets
281.05K
0.02
14.84
10.98
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.13-0.16-23.08
Q02 2022-0.15-0.1313.33
Q01 2022-0.13-0.16-23.08
Q04 2021-0.20-0.1525.00
Q03 2021-0.15-0.20-33.33
Q02 2021-0.12-0.15-25.00
Q01 2021--0.15-
Q03 2020-1.03-0.2872.82
Earnings Per EndEstimateRevision %Trend
3/2022 QR-0.120.00-
3/2022 QR-0.1131.25Positive
3/2022 FY-0.58-3.57Negative
3/2023 FY2.46--
Next Report Date28th Jun 2022
Estimated EPS Next Report-0.12
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume366.42K
Shares Outstanding15.41K
Shares Float15.31M
Trades Count855
Dollar Volume417.10K
Avg. Volume368.96K
Avg. Weekly Volume379.54K
Avg. Monthly Volume396.35K
Avg. Quarterly Volume331.00K

Aethlon Medical Inc. (NASDAQ: AEMD) stock closed at 1.06 per share at the end of the most recent trading day (a -3.64% change compared to the prior day closing price) with a volume of 483.36K shares and market capitalization of 18.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8 people. Aethlon Medical Inc. CEO is Charles J. Fisher.

The one-year performance of Aethlon Medical Inc. stock is -79.5%, while year-to-date (YTD) performance is -43.01%. AEMD stock has a five-year performance of -97.02%. Its 52-week range is between 0.88 and 6.22, which gives AEMD stock a 52-week price range ratio of 5.43%

Aethlon Medical Inc. currently has a PE ratio of -1.80, a price-to-book (PB) ratio of 0.82, a price-to-sale (PS) ratio of 58.11, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -52.77%, a ROC of -54.43% and a ROE of -56.52%. The company’s profit margin is -%, its EBITDA margin is -2 783.90%, and its revenue ttm is $281.05 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Aethlon Medical Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Aethlon Medical Inc.’s next earnings report date is 28th Jun 2022.

The consensus rating of Wall Street analysts for Aethlon Medical Inc. is Strong Buy (1), with a target price of $7, which is +498.29% compared to the current price. The earnings rating for Aethlon Medical Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aethlon Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aethlon Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.01, ATR14 : 0.12, CCI20 : -24.50, Chaikin Money Flow : -0.34, MACD : -0.04, Money Flow Index : 52.31, ROC : -7.02, RSI : 47.06, STOCH (14,3) : 57.43, STOCH RSI : 0.75, UO : 38.02, Williams %R : -42.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aethlon Medical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aethlon Medical Inc.

Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment.

CEO: Charles J. Fisher

Telephone: +1 858 459-7800

Address: 9635 Granite Ridge Drive, San Diego 92123, CA, US

Number of employees: 8

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

72%28%

Bearish Bullish

68%32%

Bearish Bullish

65%35%

News

Stocktwits